Pattern of Retinopathy: Although the locus of toxic damage is parafoveal in many eyes, Asian patients often show an extramacular pattern of damage. Dose: We recommend a maximum daily HCQ use of 5.0 mg/kg real weight, which correlates better with risk than ideal weight. Chloroquine package insert Hydroxychloroquine and phototherapy combination morphea Plaquenil alopecia areata alopecia totalis Taking plaquenil over 2 years Dec 04, 2014 Hydroxychloroquine HCQ is an anti-malarial medication that has in recent times been utilized as treatment for a variety of autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, and other inflammatory and dermatologic conditions. Hydroxychloroquine is a front-line treatment for systemic lupus erythematosus and other rheumatic diseases, but can cause retinopathy. Improved detection techniques for the early stages pre. Hydroxychloroquine retinopathy, it is important you ask your GP or specialist to refer you for screening. Progression of retinopathy. In most cases it is expected that stopping the hydroxychloroquine treatment will stop the. retinopathy worsening. If the condition does progress, a person may. experience significant loss of vision over time. Risk of Toxicity: The risk of toxicity is dependent on daily dose and duration of use. There are no similar demographic data for CQ, but dose comparisons in older literature suggest using 2.3 mg/kg real weight. Treatment of hydroxychloroquine retinopathy Hydroxychloroquine Retinopathy, Glucocorticosteroid Induced Cataracts., Hydroxychloroquine retinopathy — implications of research. In regards to malaria what is chloroquine resistance Chloroquine is a potent drug used for the treatment of various diseases, including malaria and a range of connective tissue disorders. Chloroquine retinopathy is an important complication that may appear even years after cessation of the drug, presenting with impaired visual acuity, central vision loss and progressive damage that could result in irreversible blindness. A detailed patient. Chloroquine Retinopathy Symptoms, Diagnosis and Treatment - Symptoma. Eye screening for patients taking hydroxychloroquine Plaquenil®. Chloroquine and Hydroxychloroquine Toxicity Treatment & Management.. Hydroxychloroquine retinopathy becomes more likely the longer any individual is taking the medication. The disorder is rarely seen within the first five years of treatment, but becomes more common with a longer duration of use. Between 20 and 50% of people taking hydroxychloroquine for more than 20 years may have some signs of. The recommendations on eye screening for hydroxychloroquine or chloroquine retinopathy have been revised by the American Academy of Ophthalmology. 22 It is strongly recommended that all patients beginning hydroxychloroquine or chloroquine therapy have a baseline examination within the first year of starting the drug to document any complicating. Chloroquine retinopathy, is a form of toxic retinopathy damage of the retina caused by the drugs chloroquine or hydroxychloroquine, which are sometimes used in the treatment of autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. This eye toxicity limits long-term use of the drugs.